Skip to main content

Table 1 Effect of sunitinib and DC101 on axillary lymph node and lung metastasis from MDA-MB-231LN in the m.f.p. model

From: Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3

Treatment Axillary lymph node metastases (right, left) Lung metastases
Control 14/14 (13, 6) 12/14
DC101 10/15 (10, 1) 9/15
Sunitinib 5/15a (5, 0) 3/15a
  1. In the experiment illustrated in Figure 5, axillary lymph node and lung metastases were confirmed by bioluminescent imaging ex vivo. Values are shown as the number of mice with metastasis in each organ. The statistical analysis is described in the Materials and Methods section. The results were considered to be statistically significant at P < 0.05. aP < 0.05 as compared with control.